The link you have selected will take you to a site outside xeneticbio.com.

Xenetic Biosciences, Inc. does not review or control the content of any non-Xenetic Biosciences, Inc. site. Xenetic Biosciences, Inc. does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Xenetic Biosciences, Inc. sites.

Xenetic Biosciences, Inc.

menu

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Partners
    • Careers
  • Technology
    • DNase I Oncology Platform
    • Publications
  • Pipeline
    • Overview
    • XBIO-015
    • XBIO-020
  • News & Media
    • Press Releases
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • Proxy Materials
    • SEC Filings
    • Corporate Governance
  • Contact
  • Xenetic Biosciences, Inc. on Twitter
  • Xenetic Biosciences, Inc. on Facebook
  • Xenetic Biosciences, Inc. on LinkedIn
Nasdaq: XBIO
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Information
    • Financials
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Proxy Materials
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/15/16 3 Initial statement of beneficial ownership of securities HTML PDF 2
11/15/16 3 Initial statement of beneficial ownership of securities HTML PDF 2
11/14/16 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
HTML PDF XBRL Viewer XLS XBRL Files 27
11/03/16 424B4 Prospectus filed pursuant to Rule 424(b)(4) HTML PDF 179
11/01/16 EFFECT Notice of Effectiveness HTML PDF 1
11/01/16 CERTNAS Certification by the NASDAQ Stock Exchange approving securities for listing HTML PDF 1
11/01/16 8-A12B/A Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) HTML PDF 2
11/01/16 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) HTML PDF 2
10/31/16 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. HTML PDF 1
10/31/16 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. HTML PDF 1
RSS
  • << Previous
  • 1...
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • ...46
  • Next >>

Get Email Alerts

Stay informed about our latest news and updates

Sign up Today
© 2025Xenetic Biosciences, Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap